Please note, Non-subscribed users are limited in the number of primary data page views. This includes: Fund and Manager profiles, Fund search results, and ESG category information/fund lists.
Guests can view a maximum of 10 pages. Registered users can view 10 pages per day, and subscribed users get unlimited access
Genetic engineering/GMO
Genetic engineering, particularly in agriculture and pharmaceuticals, raises concerns about bioethics and environmental impacts. Investors might exclude companies involved in controversial applications of genetic technology or engage with them to ensure ethical practices are upheld.
Fund managers employ strict policies to minimise their portfolios' exposure to genetic engineering. Some funds completely exclude companies involved in the production of GMOs, while others impose limits on the proportion of their portfolio or a company's earnings derived from the distribution of GMO products, setting caps at around 10% to 15%. Additionally, there are funds that aim for zero exposure to GMOs, excluding any company that generates revenue from activities such as GMO seed manufacturing.
FundsInsights
22 May 2024Genetic Engineering: The Ethical Dilemma for...ESGCheck
Genetic engineering, also known as genetic modification, involves directly manipulating an organism's DNA to alter its characteristics in a specific way. This technology has revolutionised fields like medicine, agriculture, and biotechnology by enabling the creation of organisms with desired traits. However, it also raises significant ethical, societal, and environmental concerns that influence investor decisions.
10 Apr 2024ESG and RI: Beauty is in the eye of the beholderESGCheck
One of the most significant trends impacting managed funds and investment management has been the trend towards ESG - otherwise known as Environmental, Social & Governance, or more broadly, RI or Responsible Investment. According to some sources - particularly those who are strong advocates of the cause - 83% of investors consider ESG or RI to be a significant factor in their invest decision or choice of a managed fund. That may well be the case, but finding funds that meet an individual investor's requirements is anything but simple.
Genetic engineering/GMO
